Identifying individual psychosocial and adherence support needs in patients with psoriasis: a multinational two-stage qualitative and quantitative study

por Bewley, A, Burrage, D M, Ersser, S J, Hansen, M, Ward, C
Publicado 2014

Pathological margins and advanced cutaneous squamous cell carcinoma of the head and neck

por Phillips, T. J., Harris, B. N., Moore, M. G., Farwell, D. G., Bewley, A. F.
Publicado 2019

Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching‐adjusted...

por Bewley, A.P., Shear, N.H., Calzavara‐Pinton, P.G., Hansen, J.B., Nyeland, M.E., Signorovitch, J.
Publicado 2019

Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from t...

por Reich, K., Gooderham, M., Bewley, A., Green, L., Soung, J., Petric, R., Marcsisin, J., Cirulli, J., Chen, R., Piguet, V.
Publicado 2018

Psychological and professional impact of COVID-19 lockdown on French dermatologists: Data from a large survey

por Misery, L., Fluhr, J.-W., Beylot-Barry, M., Jouan, N., Hamann, P., Consoli, S.-G., Schollhammer, M., Charleux, D., Bewley, A., Rathod, D.
Publicado 2021

The efficacy and safety of apremilast, etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from a phase IIIb, randomized, placebo‐controlle...

por Reich, K., Gooderham, M., Green, L., Bewley, A., Zhang, Z., Khanskaya, I., Day, R.M., Goncalves, J., Shah, K., Piguet, V., Soung, J.
Publicado 2016

Brimonidine gel 0.33% rapidly improves patient‐reported outcomes by controlling facial erythema of rosacea: a randomized, double‐blind, vehicle‐controlled study

por Layton, A.M., Schaller, M., Homey, B., Hofmann, M.A., Bewley, A.P., Lehmann, P., Nohlgård, C., Sarwer, D.B., Kerrouche, N., Ma, Y.M.
Publicado 2015

Autofluorescence lifetime augmented reality as a means for real-time robotic surgery guidance in human patients

por Gorpas, D., Phipps, J., Bec, J., Ma, D., Dochow, S., Yankelevich, D., Sorger, J., Popp, J., Bewley, A., Gandour-Edwards, R., Marcu, L., Farwell, D. G.
Publicado 2019

A multinational, prospective, observational study to estimate complete skin clearance in patients with moderate‐to‐severe plaque PSOriasis treated with BIOlogics in a REAL world se...

por Seneschal, J., Lacour, J.‐P., Bewley, A., Faurby, M., Paul, C., Pellacani, G., De Simone, C., Horne, L., Sohrt, A., Augustin, M., Hammond, E., Reich, K.
Publicado 2020

Freedom from disease in psoriasis: a Delphi consensus definition by patients, nurses and physicians

por van Ee, I., Deprez, E., Egeberg, A., Augustin, M., Conrad, C., Corazza, V., Donati, L., Lambert, J., Lăpădatu, R., Meyer, A., Paul, C., Penzer‐Hick, R., Stephen, K., van der Zon, J., Bewley, A.
Publicado 2021

Identifying the best predictive diagnostic criteria for psoriasis in children (< 18 years): a UK multicentre case–control diagnostic accuracy study (DIPSOC study)

por Burden‐Teh, E., Murphy, R., Gran, S., Nijsten, T., Hughes, C., Abdul‐Wahab, A., Bewley, A., Burrows, N., Darne, S., Gach, J.E., Katugampola, R., Jury, C.S., Kuet, K., Llewellyn, J., McPherson, T., Ravenscroft, J.C., Taibjee, S., Wilkinson, C., Thomas, K.S.
Publicado 2021

Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel

por Schaller, M., Almeida, L.M.C., Bewley, A., Cribier, B., Del Rosso, J., Dlova, N.C., Gallo, R.L., Granstein, R.D., Kautz, G., Mannis, M.J., Micali, G., Oon, H.H., Rajagopalan, M., Steinhoff, M., Tanghetti, E., Thiboutot, D., Troielli, P., Webster, G., Zierhut, M., van Zuuren, E.J., Tan, J.
Publicado 2019